Ex Vivo Formation of Blood Vessels
Vascular bypass grafts represent a well-grounded technological advance in the new millennium, this being related to the high prevalence of atherosclerosis and the ensuing treatment of myocardial infarction [1]. However, more recently a paradigm shift has
- PDF / 513,789 Bytes
- 8 Pages / 547.087 x 737.008 pts Page_size
- 71 Downloads / 252 Views
		    ntents 47.1 
 
 Introduction  . . . . . . . . . . . . . . . . . . . . . . . .   685
 
 47.2 
 
 Ideal Vascular Graft  . . . . . . . . . . . . . . . . . .   686
 
 47.3 
 
 Tissue-Engineered Vascular Grafts  . . . . . .   686
 
 47.3.1 Scaffold  . . . . . . . . . . . . . . . . . . . . . . . . . . .   687 47.3.2 Matrix  . . . . . . . . . . . . . . . . . . . . . . . . . . . . .   688 47.3.3 Endothelialisation  . . . . . . . . . . . . . . . . . . . .   689 47.4 
 
 Current Problems  . . . . . . . . . . . . . . . . . . . .   689
 
 47.5 
 
 Conclusion  . . . . . . . . . . . . . . . . . . . . . . . . .   690 References  . . . . . . . . . . . . . . . . . . . . . . . . .   691
 
 47.1 
 
 Introduction
 
 Vascular bypass grafts represent a well-grounded technological advance in the new millennium, this being related to the high prevalence of atherosclerosis and the ensuing treatment of myocardial infarction [1]. However, more recently a paradigm shift has occurred casting the subject of vascular tissue engineering in new light. The development of cardiovascular devices both for high- and low-flow scenarios in the form of functional vascular prostheses has
 
 47 
 
 made this possible. While the patency rates of highflow vessels [2], such as polyethylene terephthalate (Dacron) and expanded polytetrafluoroethylene (ePTFE) grafts following prolonged clinical use are acceptable, these figures are less satisfactory at lower flow rates [3]. Given the limitations with synthetic materials alone, a biological or biohybrid vascular prosthesis could provide us with the ideal blood vessel substitute. The current interest in developing artificial organs such as the tissue-engineered bladders [4] and composite tissue has sparked renewed interest in this field. In the latter case, the limitations of immunogenicity with allotransplantation [5] have put the development of these blood vessels, and in particular the development of artificial capillary systems [6], at the forefront. Such integrated vascular networks would serve to nourish the various tissue planes within a tissue-engineered construct [7]. This has formed the basis for the emphasis of developing small-calibre (		
Data Loading...
 
	 
	 
	 
	 
	 
	 
	 
	 
	 
	 
	